The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)

被引:10
作者
Corbin, Laura J. [1 ,2 ]
Hughes, David A. [1 ,2 ]
Bull, Caroline J. [1 ,2 ]
Vincent, Emma E. [1 ,3 ]
Smith, Madeleine L. [1 ,2 ]
McConnachie, Alex [4 ]
Messow, Claudia-Martina [4 ]
Welsh, Paul [5 ]
Taylor, Roy [6 ]
Lean, Michael E. J. [7 ]
Sattar, Naveed [5 ]
Timpson, Nicholas J. [1 ,2 ]
机构
[1] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, England
[2] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, England
[3] Univ Bristol, Sch Translat Hlth Sci, Dorothy Hodgkin Bldg, Bristol, England
[4] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow, Scotland
[5] Univ Glasgow, Sch Cardiovasc & Metab Hlth, Glasgow, Scotland
[6] Newcastle Univ, Translat & Clin Res Inst, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne, England
[7] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Human Nutr, Glasgow, Scotland
基金
英国惠康基金;
关键词
Diabetes remission; DiRECT; Metabolomics; Randomised controlled trial; Type; 2; diabetes; Weight loss; INSULIN-RESISTANCE; BARIATRIC SURGERY; GASTRIC BYPASS; FATTY-ACID; TYPE-2; PLASMA; ERYTHRITOL; ADIPOSITY; FEATURES; OBESITY;
D O I
10.1007/s00125-023-06019-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesisHigh-throughput metabolomics technologies in a variety of study designs have demonstrated a consistent metabolomic signature of overweight and type 2 diabetes. However, the extent to which these metabolomic patterns can be reversed with weight loss and diabetes remission has been weakly investigated. We aimed to characterise the metabolomic consequences of a weight-loss intervention in individuals with type 2 diabetes.MethodsWe analysed 574 fasted serum samples collected within an existing RCT (the Diabetes Remission Clinical Trial [DiRECT]) (N=298). In the trial, participating primary care practices were randomly assigned (1:1) to provide either a weight management programme (intervention) or best-practice care by guidelines (control) treatment to individuals with type 2 diabetes. Here, metabolomics analysis was performed on samples collected at baseline and 12 months using both untargeted MS and targeted 1H-NMR spectroscopy. Multivariable regression models were fitted to evaluate the effect of the intervention on metabolite levels.ResultsDecreases in branched-chain amino acids, sugars and LDL triglycerides, and increases in sphingolipids, plasmalogens and metabolites related to fatty acid metabolism were associated with the intervention (Holm-corrected p<0.05). In individuals who lost more than 9 kg between baseline and 12 months, those who achieved diabetes remission saw greater reductions in glucose, fructose and mannose, compared with those who did not achieve remission.Conclusions/interpretationWe have characterised the metabolomic effects of an integrated weight management programme previously shown to deliver weight loss and diabetes remission. A large proportion of the metabolome appears to be modifiable. Patterns of change were largely and strikingly opposite to perturbances previously documented with the development of type 2 diabetes.Data availabilityThe data used for analysis are available on a research data repository (https://researchdata.gla.ac.uk/) with access given to researchers subject to appropriate data sharing agreements. Metabolite data preparation, data pre-processing, statistical analyses and figure generation were performed in R Studio v.1.0.143 using R v.4.0.2. The R code for this study has been made publicly available on GitHub at: https://github.com/lauracorbin/metabolomics_of_direct.
引用
收藏
页码:74 / 87
页数:14
相关论文
共 43 条
  • [1] Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes
    Abu Bakar, Mohamad Hafizi
    Sarmidi, Mohamad Roji
    Cheng, Kian-Kai
    Khan, Abid Ali
    Suan, Chua Lee
    Huri, Hasniza Zaman
    Yaakob, Harisun
    [J]. MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1742 - 1774
  • [2] Alam Yasmine Henna, 2022, J Lipid Atheroscler, V11, P20, DOI 10.12997/jla.2022.11.1.20
  • [3] Metabolomics of Type 1 and Type 2 Diabetes
    Arneth, Borros
    Arneth, Rebekka
    Shams, Mohamed
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [4] Early Metabolic Features of Genetic Liability to Type 2 Diabetes: Cohort Study With Repeated Metabolomics Across Early Life
    Bell, Joshua A.
    Bull, Caroline J.
    Gunter, Marc J.
    Carslake, David
    Mahajan, Anubha
    Davey Smith, George
    Timpson, Nicholas J.
    Vincent, Emma E.
    [J]. DIABETES CARE, 2020, 43 (07) : 1537 - 1545
  • [5] Detection of recent ethanol intake with new markers: Comparison of fatty acid ethyl esters in serum and of ethyl glucuronide and the ratio of 5-hydroxytryptophol to 5-hydroxyindole acetic acid in urine
    Borucki, K
    Schreiner, R
    Dierkes, J
    Jachau, K
    Krause, D
    Westphal, S
    Wurst, FM
    Luley, C
    Schmidt-Gayk, H
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 781 - 787
  • [6] Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk
    Cirulli, Elizabeth T.
    Guo, Lining
    Swisher, Christine Leon
    Shah, Naisha
    Huang, Lei
    Napier, Lori A.
    Kirkness, Ewen F.
    Spector, Tim D.
    Caskey, C. Thomas
    Thorens, Bernard
    Venter, J. Craig
    Telenti, Amalio
    [J]. CELL METABOLISM, 2019, 29 (02) : 488 - +
  • [7] Metabolomics: an emerging but powerful tool for precision medicine
    Clish, Clary B.
    [J]. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2015, 1 (01):
  • [8] Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Davies, Melanie J.
    Aroda, Vanita R.
    Collins, Billy S.
    Gabbay, Robert A.
    Green, Jennifer
    Maruthur, Nisa M.
    Rosas, Sylvia E.
    Del Prato, Stefano
    Mathieu, Chantal
    Mingrone, Geltrude
    Rossing, Peter
    Tankova, Tsvetalina
    Tsapas, Apostolos
    Buse, John B.
    [J]. DIABETES CARE, 2022, 45 (11) : 2753 - 2786
  • [9] Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
    Guasch-Ferre, Marta
    Hruby, Adela
    Toledo, Estefania
    Clish, Clary B.
    Martinez-Gonzalez, Miguel A.
    Salas-Salvado, Jordi
    Hu, Frank B.
    [J]. DIABETES CARE, 2016, 39 (05) : 833 - 846
  • [10] METABOLISM OF ERYTHRITOL IN HUMANS - COMPARISON WITH GLUCOSE AND LACTITOL
    HIELE, M
    GHOOS, Y
    RUTGEERTS, P
    VANTRAPPEN, G
    [J]. BRITISH JOURNAL OF NUTRITION, 1993, 69 (01) : 169 - 176